ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc (RPHM)

1.46
-0.04
( -2.67% )
Updated: 10:44:24

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.46
Bid
1.46
Ask
1.54
Volume
72,532
1.45 Day's Range 1.58
0.9801 52 Week Range 9.21
Market Cap
Previous Close
1.50
Open
1.50
Last Trade
1
@
1.47
Last Trade Time
10:44:45
Financial Volume
$ 109,355
VWAP
1.5077
Average Volume (3m)
118,616
Shares Outstanding
33,428,808
Dividend Yield
-
PE Ratio
-0.65
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-77.39M

About Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $1.50. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 0.9801 to $ 9.21.

Reneo Pharmaceuticals currently has 33,428,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $50.14 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.65.

RPHM Latest News

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.128.95522388061.341.571.25014657471.39962816CS
4-0.07-4.575163398691.531.691.25011636121.43732363CS
12-0.11-7.006369426751.571.691.25011186161.46245958CS
26-0.18-10.97560975611.641.931.25011804521.59355152CS
52-5.54-79.142857142979.210.98014111862.21190718CS
156-6.14-80.78947368427.611.2950.98011865573.13603318CS
260-13.84-90.457516339915.316.830.98011742633.65108718CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZEOZeo Energy Corporation
$ 3.5599
(212.27%)
41.11M
TBIOTelesis Bio Inc
$ 3.23
(137.50%)
43.89M
XCURExicure Inc
$ 4.5607
(99.16%)
12.01M
GSIWGarden Stage Ltd
$ 4.30
(89.43%)
8.83M
RZLVRezolve AI Ltd
$ 7.41
(56.00%)
5.73M
HAOHaoxi Health Technology Ltd
$ 0.739951
(-75.33%)
5M
GLXGGalaxy Payroll Group Ltd
$ 3.83
(-36.80%)
849.47k
GDHGGolden Heaven Group Holdings Ltd
$ 2.70
(-35.25%)
234.25k
PGNYProgyny Inc
$ 17.41
(-28.76%)
8.74M
VVOSVivos Therapeutics Inc
$ 3.02
(-26.88%)
2.16M
NVDANVIDIA Corporation
$ 118.88
(4.86%)
105.56M
SQQQProShares UltraPro Short QQQ
$ 7.72
(-8.10%)
95.12M
FRGTFreight Technologies Inc
$ 0.1358
(9.60%)
65.89M
TBIOTelesis Bio Inc
$ 3.23
(137.50%)
43.9M
MAXNMaxeon Solar Technologies Ltd
$ 0.09895
(8.86%)
41.29M

Your Recent History

Delayed Upgrade Clock